CME Group (NASDAQ:CME) Releases Quarterly Earnings Results, Beats Expectations By $0.03 EPS

CME Group (NASDAQ:CME) announced its earnings results on Wednesday. The financial services provider reported $2.68 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.65 by $0.03, Briefing.com reports. The business had revenue of $1.58 billion for the quarter, compared to analyst estimates of $1.59 billion. CME Group had a net margin of 56.98% and a return on equity of 12.82%. The company’s revenue for the quarter was up 18.4% compared to the same quarter last year. During the same period last year, the firm posted $2.25 earnings per share.

CME Group Price Performance

Shares of CME opened at $229.69 on Friday. The company has a market capitalization of $82.70 billion, a price-to-earnings ratio of 26.13, a P/E/G ratio of 7.76 and a beta of 0.55. The company has a debt-to-equity ratio of 0.10, a current ratio of 1.02 and a quick ratio of 1.02. The business’s 50-day moving average is $218.08 and its 200-day moving average is $208.66. CME Group has a fifty-two week low of $190.70 and a fifty-two week high of $230.36.

CME Group Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Wednesday, September 25th. Stockholders of record on Monday, September 9th were given a $1.15 dividend. This represents a $4.60 annualized dividend and a dividend yield of 2.00%. The ex-dividend date of this dividend was Monday, September 9th. CME Group’s dividend payout ratio (DPR) is currently 52.33%.

Analyst Ratings Changes

CME has been the subject of a number of recent research reports. Redburn Atlantic cut shares of CME Group from a “buy” rating to a “neutral” rating and set a $244.00 price target for the company. in a research note on Tuesday, October 8th. Deutsche Bank Aktiengesellschaft upped their price objective on CME Group from $193.00 to $200.00 and gave the company a “hold” rating in a research note on Thursday, August 15th. The Goldman Sachs Group lifted their target price on CME Group from $195.00 to $198.00 and gave the company a “sell” rating in a research note on Thursday, October 3rd. Piper Sandler upped their price target on CME Group from $225.00 to $240.00 and gave the stock an “overweight” rating in a research note on Tuesday, October 8th. Finally, Royal Bank of Canada reiterated a “sector perform” rating and issued a $235.00 price objective on shares of CME Group in a research report on Thursday. Four research analysts have rated the stock with a sell rating, seven have assigned a hold rating and four have given a buy rating to the company’s stock. According to MarketBeat.com, CME Group presently has a consensus rating of “Hold” and an average price target of $222.07.

Insider Buying and Selling at CME Group

In related news, Director Bryan T. Durkin sold 7,593 shares of the firm’s stock in a transaction that occurred on Friday, August 30th. The stock was sold at an average price of $214.59, for a total value of $1,629,381.87. Following the transaction, the director now directly owns 55,607 shares of the company’s stock, valued at approximately $11,932,706.13. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. In related news, CFO Lynne Fitzpatrick sold 754 shares of the firm’s stock in a transaction that occurred on Sunday, September 15th. The stock was sold at an average price of $216.99, for a total transaction of $163,610.46. Following the completion of the transaction, the chief financial officer now owns 13,261 shares in the company, valued at $2,877,504.39. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Bryan T. Durkin sold 7,593 shares of the business’s stock in a transaction that occurred on Friday, August 30th. The stock was sold at an average price of $214.59, for a total value of $1,629,381.87. Following the completion of the transaction, the director now directly owns 55,607 shares in the company, valued at $11,932,706.13. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 0.30% of the company’s stock.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.